Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience.


Atalar B. , Ozsahin M., Call J., Napieralska A., Kamer S., Villa S., et al.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, cilt.127, ss.96-102, 2018 (SCI İndekslerine Giren Dergi)

  • Cilt numarası: 127 Konu: 1
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1016/j.radonc.2017.12.028
  • Dergi Adı: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • Sayfa Sayısı: ss.96-102

Özet

Background and purpose: The optimal treatment for adults with newly diagnosed medulloblastoma (MB) has not been defined. We report a large series of cases from the Rare Cancer Network.